RT Journal Article SR Electronic T1 Intraocular water movement visualization using 1H-MRI with eye drops of O-17 labeled saline: a first-in-human study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.02.13.22270420 DO 10.1101/2022.02.13.22270420 A1 Tomiyasu, Moyoko A1 Sahara, Yasuka A1 Mitsui, Etsuko A1 Tsuchiya, Hiroki A1 Maeda, Takamasa A1 Tomoyori, Nobuhiro A1 Kawashima, Makoto A1 Nogawa, Toshifumi A1 Kishimoto, Riwa A1 Takado, Yuhei A1 Higashi, Tatsuya A1 Mizota, Atsushi A1 Kudo, Kohsuke A1 Obata, Takayuki YR 2022 UL http://medrxiv.org/content/early/2022/02/16/2022.02.13.22270420.abstract AB Background Visualization of aqueous humor flow in the human eye is difficult because gadolinium, a magnetic resonance imaging (MRI) contrast agent, does not readily cross the blood-retinal and blood-aqueous barriers of capillaries that supply water to the eye. The proton (1H) of oxygen-17 water (H217O) has a very short transverse relaxation time (T2), and the T2-weighted (T2W) 1H-MRI signal intensity of a region with H217O is lower than that with only H2 16O.Purpose To observe the distribution of H217O in the human eye, and the flow into and out of the anterior chamber of H217O, using dynamic T2W 1H-MRI.Materials and Methods Seven ophthalmologically normal adult volunteers under 40 years old participated in this study. During dynamic imaging, the subject self-administered 10 mol% H217O saline (0.92–1.37 mL) to their right eye for 1 min. Time-series images were created by subtracting the image before the eye drops from each of the images obtained after the eye drops. The “normalized signal intensity of the right anterior chamber” (rAC) in each image was obtained by dividing the signal intensity of the right anterior chamber region-of-interest by that of the left. Changes in transverse relaxation rate and H217O concentration (PO17) were calculated from the rAC. The inflow and outflow constants of H217O in the right anterior chamber were also determined.Results Decreased signal intensity after the H217O eye drops was observed in the anterior and posterior chambers, but not in the vitreous body. The rAC signal intensity decreased after the eye drops, and then recovered to close to rAC(0) at 40 min. The inflow and outflow constants were 0.53 ± 0.19 and 0.055 ± 0.019 min-1, respectively, and the peak value of PO17 was 0.19 ± 0.04% (mean ± SD).Conclusion H217O saline eye drops distributed in the human anterior and posterior chambers. Further, the eye drops smoothly flowed into, and slowly out of, the anterior chamber.Summary O-17 water dropped into human eyes as a T2-weighted MRI contrast agent was distributed in the anterior and posterior chambers, with smooth flow into, and slow outflow from, the anterior chamber.Key findings In seven healthy volunteers, dynamic T2-weighted 1H-MRI showed that the signal intensity in the anterior chamber decreased smoothly after H217O eye drops and then slowly recovered, reaching a value close to that observed before the eye drops, after 40 minutes, with inflow and outflow constants of H217O of 0.53 ± 0.19 min-1 and 0.055 ± 0.019 min-1, respectively. The signal changes were limited to the anterior and posterior chambers and were not observed in the vitreous body.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialjRCTs031210082Funding StatementThis work was supported by a Grant-in-Aid (Public/Private R&D Investment Strategic Expansion PrograM: PRISM) from the Cabinet Office, Japan.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the National Institutes for Quantum Science and Technology (approval number CRB3180004).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in the present study are available from the corresponding author upon reasonable request.dT2W_MRIdynamic T2W 1H-MRIΔR2, Htransverse relaxation rate change of the H2O protonH217Ooxygen-17 waterIQRinterquartile rangePO17the molar fraction of H217OR2, Htransverse relaxation rate of the H2O protontransverse relaxation rate of the H216O protontransverse relaxation rate of the H217O protonrACnormalized signal intensity of the right anterior chamberROIregion of interest